Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.07.2021 | Case report

Clozapine/haloperidol/olanzapine

Lack of efficacy and allergy presented as creatine kinase elevation: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Jonker N, et al. Creatine kinase elevation and discontinuation of clozapine: Fear-driven clinical practice in a forensic case with treatment-resistant schizophrenia and persistent violent behaviour. BJPsych open 7: e4, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1192/bjo.2020.134 Jonker N, et al. Creatine kinase elevation and discontinuation of clozapine: Fear-driven clinical practice in a forensic case with treatment-resistant schizophrenia and persistent violent behaviour. BJPsych open 7: e4, No. 1, Jan 2021. Available from: URL: http://​doi.​org/​10.​1192/​bjo.​2020.​134
Metadaten
Titel
Clozapine/haloperidol/olanzapine
Lack of efficacy and allergy presented as creatine kinase elevation: case report
Publikationsdatum
01.07.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-99048-7

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Erenumab

Case report

Ribavirin

Case report

Methotrexate